Gyre Therapeutics GYRE
NASDAQ GYRE
$7.11 +0.11 (+1.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Shares Outstanding (Entity) (2010 - 2026)

Updated

Gyre Therapeutics (GYRE) recorded Shares Outstanding (Entity) of 106.03 million in Q2 2026, up 16.7% from 90.82 million a year earlier and up 16.1% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

For FY2025, Gyre Therapeutics reported Shares Outstanding (Entity) of 91.31 million, up 5.8% from FY2024.

  • Annual Shares Outstanding (Entity) has a five-year compound annual growth rate of 128.3% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Entity) came in at 86.31 million in FY2024 (+12.7%), 76.6 million in FY2023, 2.52 million in FY2022 (+20.2%) and 2.09 million in FY2021 (+42.1%).
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q2 2010.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased for seven consecutive quarters, with growth averaging 7.7% over the last seven quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.4% (Q3 2022) and 42.1% (Q4 2021) over the last five years.
  • Per Business Quant, the preceding three quarters came in at 91.34 million (Q1 2026), 91.31 million (Q4 2025) and 90.89 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 941.36 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.41 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 1.77 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 540.60 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.24 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 5.70 Bn
10 Gyre Therapeutics 742.24 Mn 544.95 Mn 26.90 Mn 106.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 106.03 Mn
Mar 31, 2026 91.34 Mn
Dec 31, 2025 91.31 Mn
Sep 30, 2025 90.89 Mn
Jun 30, 2025 90.82 Mn
Mar 31, 2025 87.64 Mn
Dec 31, 2024 86.31 Mn
Sep 30, 2024 85.77 Mn
Jun 30, 2024 85.54 Mn
Mar 31, 2024 85.42 Mn
Dec 31, 2023 76.60 Mn
Sep 30, 2023 2.53 Mn
Jun 30, 2023 2.53 Mn
Mar 31, 2023 2.52 Mn
Dec 31, 2022 2.52 Mn
Sep 30, 2022 2.10 Mn
Jun 30, 2022 2.10 Mn
Mar 31, 2022 2.10 Mn
Dec 31, 2021 2.09 Mn
Sep 30, 2021 2.09 Mn
API Access

Gyre Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=GYRE&period=max&api_key=YOUR_API_KEY